SCHEMBL2307656

SCHEMBL2307656

OCCc1ccc2c(c1)[nH]c1ccc(CCO)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 5/20 0.49
HPGD P15428 3/20 0.49
MAPT P10636 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KIF11 P52732 6/20 0.47
ALOX5 P09917 1/20 0.42
GAA P10253 1/20 0.42
BACE1 P56817 1/20 0.42
AHR P35869 1/20 0.41
PIKFYVE Q9Y2I7 1/20 0.39
MAOA P21397 1/20 0.39
DYRK1A Q13627 1/20 0.39
CA2 P00918 1/20 0.38
BAD Q92934 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312893 0.92 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL2313068 0.92 KIF11 (0.48) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL8161592 0.89 PTGS2 (0.48) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL2312163 0.87 KIF11 (0.64) ALDH1A1KDM4EHPGDHSD17B10KIF11
SCHEMBL2311195 0.87 AHR (0.53) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL28335170 0.76 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL29844524 0.76 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL31509995 0.74 KIF11 (0.58) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL2315719 0.74 MAPT (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL2311073 0.74 MAOA (0.43) ALDH1A1KDM4EMAPTKIF11ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed